SG Americas Securities
VRTX icon

SG Americas Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

SG Americas Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.4M Sell
56,982
-58,917
-51% -$27.5M 0.03% 459
2025
Q4 		$52.5M Buy
115,899
+55,837
+93% +$24.1M 0.07% 220
2025
Q3 		$23.5M Sell
60,062
-55,578
-48% -$23.2M 0.08% 164
2025
Q2 		$51.5M Buy
115,640
+93,367
+419% +$43M 0.21% 65
2025
Q1 		$10.8M Buy
22,273
+17,502
+367% +$8.16M 0.04% 292
2024
Q4 		$1.92M Sell
4,771
-30,560
-86% -$14.2M 0.01% 611
2024
Q3 		$16.4M Sell
35,331
-43,198
-55% -$20.8M 0.06% 195
2024
Q2 		$36.8M Buy
78,529
+48,495
+161% +$21M 0.21% 97
2024
Q1 		$12.6M Buy
30,034
+1,911
+7% +$808K 0.06% 310
2023
Q4 		$11.4M Buy
28,123
+14,427
+105% +$5.33M 0.11% 184
2023
Q3 		$4.76M Sell
13,696
-16,367
-54% -$5.72M 0.05% 307
2023
Q2 		$10.6M Buy
30,063
+13,487
+81% +$4.54M 0.08% 163
2023
Q1 		$5.22M Sell
16,576
-1,869
-10% -$561K 0.06% 257
2022
Q4 		$5.33M Buy
18,445
+4,112
+29% +$1.25M 0.06% 253
2022
Q3 		$4.15M Sell
14,333
-25,284
-64% -$7.27M 0.05% 296
2022
Q2 		$11.2M Sell
39,617
-35,668
-47% -$9.55M 0.12% 141
2022
Q1 		$19.6M Buy
75,285
+41,131
+120% +$9.76M 0.14% 118
2021
Q4 		$7.5M Buy
34,154
+25,894
+313% +$5.04M 0.04% 350
2021
Q3 		$1.5M Sell
8,260
-114,990
-93% -$22.5M 0.01% 1541
2021
Q2 		$24.9M Buy
123,250
+91,977
+294% +$19.2M 0.12% 150
2021
Q1 		$6.72M Sell
31,273
-13,996
-31% -$3.07M 0.04% 405
2020
Q4 		$10.7M Buy
45,269
+16,177
+56% +$3.71M 0.06% 251
2020
Q3 		$7.92M Sell
29,092
-15,628
-35% -$4.31M 0.05% 232
2020
Q2 		$13M Buy
44,720
+22,953
+105% +$6.22M 0.11% 134
2020
Q1 		$5.18M Buy
21,767
+875
+4% +$201K 0.05% 373
2019
Q4 		$4.57M Sell
20,892
-68,170
-77% -$13.8M 0.04% 416
2019
Q3 		$15.1M Buy
89,062
+55,071
+162% +$9.74M 0.12% 142
2019
Q2 		$6.23M Buy
33,991
+17,724
+109% +$3.1M 0.04% 435
2019
Q1 		$2.99M Buy
16,267
+14,328
+739% +$2.65M 0.03% 639
2018
Q4 		$321K Sell
1,939
-84,768
-98% -$14.7M ﹤0.01% 2130
2018
Q3 		$16.7M Buy
86,707
+48,849
+129% +$8.7M 0.12% 160
2018
Q2 		$6.43M Sell
37,858
-28,889
-43% -$4.48M 0.06% 340
2018
Q1 		$10.9M Buy
66,747
+51,539
+339% +$8.42M 0.09% 186
2017
Q4 		$2.28M Sell
15,208
-74
-0.5% -$11K 0.02% 790
2017
Q3 		$2.32M Buy
15,282
+1,473
+11% +$222K 0.02% 715
2017
Q2 		$1.78M Sell
13,809
-26,507
-66% -$3.19M 0.02% 972
2017
Q1 		$4.41M Sell
40,316
-58,389
-59% -$5.14M 0.04% 444
2016
Q4 		$7.27M Buy
98,705
+75,606
+327% +$6.15M 0.06% 321
2016
Q3 		$2.01M Buy
23,099
+4,031
+21% +$381K 0.02% 734
2016
Q2 		$1.64M Sell
19,068
-31,434
-62% -$2.72M 0.01% 972
2016
Q1 		$4.01M Sell
50,502
-61,662
-55% -$5.58M 0.03% 471
2015
Q4 		$14.1M Buy
112,164
+36,269
+48% +$4.38M 0.1% 170
2015
Q3 		$5.76M Sell
75,895
-147,937
-66% -$19M 0.03% 335
2015
Q2 		$27.6M Buy
223,832
+95,318
+74% +$12M 0.18% 86
2015
Q1 		$15.2M Sell
128,514
-65,410
-34% -$7.84M 0.09% 168
2014
Q4 		$23M Sell
193,924
-79,497
-29% -$8.95M 0.11% 162
2014
Q3 		$30.7M Buy
273,421
+29,615
+12% +$2.82M 0.18% 115
2014
Q2 		$23.1M Sell
243,806
-117,644
-33% -$8.25M 0.13% 135
2014
Q1 		$25.6M Buy
361,450
+85,159
+31% +$6.74M 0.11% 210
2013
Q4 		$20.5M Sell
276,291
-256,263
-48% -$17.8M 0.09% 240
2013
Q3 		$40.4M Buy
532,554
+344,265
+183% +$27.4M 0.17% 119
2013
Q2 		$15M Buy
+188,289
New +$13.9M 0.07% 278

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

SG Americas Securities's VRTX Position: Q1 2026 in Review

SG Americas Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 51% in Q1 2026, selling an estimated $27.5M and leaving 56,982 shares worth $25.4M. The position accounts for 0.03% of the portfolio, ranked #459.

SG Americas Securities first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $52.5M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • SG Americas Securities held 56,982 shares of Vertex Pharmaceuticals worth $25.4M as of Q1 2026.
  • SG Americas Securities sold 58,917 Vertex Pharmaceuticals shares in Q1 2026, an estimated $27.5M.
  • Vertex Pharmaceuticals made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #459 holding.
  • SG Americas Securities first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • SG Americas Securities's Vertex Pharmaceuticals position peaked at $52.5M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.